Fulvia Ceccarelli: Efficacy of Anifrolumab in Lupus-Associated Autoimmune Haemolytic Anaemia
Fulvia Ceccarelli, Associate Professor of Rheumatology at Sapienza University of Rome, shared a post on LinkedIn about a recent article she and her colleagues co-authores, published in Lupus Science and Medicine, adding:
“We are proud to share our last contribution on efficacy of anifrolumab on lupus autoimmune haemolytic anaemia.
The study is the result of a spontaneous and friendly collaboration among centers in various Italian region.”
Title: Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab
Authors: Fulvia Ceccarelli, Rossella De Angelis, Francesca Bottazzi, Danila Madonna, Melania Alessia Coscia, Noemi Italiano, Emanuela Praino, Emanuela Sabatini, Leonardo Santo, Lorenzo Cavagna, Fabrizio Conti

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C